What is Ciwit B.V.?
Ciwit B.V. operates as a clinical data management company, offering cloud-based electronic data capture (EDC) systems designed for clinical research and medical studies. Its platform empowers researchers to efficiently design case report forms, collect patient data, and manage clinical trial information. The company serves a diverse clientele, including pharmaceutical firms, contract research organizations (CROs), academic institutions, and healthcare providers, facilitating regulatory compliance and enhancing data quality through its user-friendly EDC technology. The recent major strategic investment signals a pivotal stage for Ciwit B.V., likely aimed at scaling operations and expanding its market reach within the competitive health tech landscape.
How much funding has Ciwit B.V. raised?
Ciwit B.V. has raised a total of $58.2M across 3 funding rounds:
Grant
$1.2M
Series A
$12M
Series B
$45M
Grant (2017): $1.2M, investors not publicly disclosed
Series A (2020): $12M led by Two Sigma Ventures, Hambrecht Ducera Growth Ventures, and INKEF Capital
Series B (2021): $45M supported by F-Prime Capital, INKEF Capital, Two Sigma Ventures, and Eight Roads Ventures
Key Investors in Ciwit B.V.
F-Prime Capital
F-Prime Capital is a venture capital firm established in 2002, with a dedicated team of investors, engineers, doctors, and scientists focused on investing in healthcare and technology companies.
INKEF Capital
INKEF Capital is an Amsterdam-based venture capital firm founded in 2010, specializing in long-term collaboration and active support for innovative technology companies, with a focus on Healthcare, Technology, IT/New Media & FinTech.
Two Sigma Ventures
Two Sigma Ventures is an early-stage venture capital firm that invests in transformative companies leveraging information growth and computing power, with a focus on technology that enhances human potential and breakthrough therapies.
What's next for Ciwit B.V.?
With a recent major strategic investment and substantial total funding, Ciwit B.V. is poised for significant expansion. The company's focus on providing robust EDC solutions for clinical research positions it to capitalize on the increasing demand for efficient and compliant data management in drug development and medical studies. Future strategies will likely involve enhancing platform capabilities, broadening its customer base across pharmaceutical and academic sectors, and potentially exploring new market segments. The strategic backing suggests a focus on accelerating product innovation and solidifying its competitive advantage in the health technology market.
See full Ciwit B.V. company page
